Takeda Stakes $1.13 Billion on Rights to Fruquintinib for Advanced Refractory Colorectal Cancer
January 23rd 2023Under the agreement, Takeda will pay Hutchmed $400 million up front and up to $730 million in additional potential payments relating to regulatory, development, and commercial sales milestones, as well as royalties on worldwide net sales, with the exception of mainland China, Hong Kong, and Macau.
Read More
Contributor: Promoting Health Equity Through Primary Care
January 23rd 2023Jodi Fenner, senior director at Elevance Health, speaks on the key themes she presented during her session at the 2023 Health Equity Summit in San Diego, California, titled, "Promoting Health Equity through Primary Care."
Read More
Health Equity Decision-making: A Q&A With Dr N. Benjamin Fredrick
January 23rd 2023N. Benjamin Fredrick, MD, of Penn State Hershey Medical Center and Penn State University College of Medicine, speaks on the key themes he presented during his session at the 2023 Health Equity Summit in San Diego, California, as well as topics related to the measurement, creation, and implementation of health equity initiatives.
Read More
Contributor: Journey to Launching a Meaningful Health Equity Strategy
January 23rd 2023Michelle Y. Williams, PhD, RN, of Stanford Health Care, speaks on the key themes she presented during her session at the 2023 Health Equity Summit in San Diego, California, titled, "Launching a Health Equity Strategy."
Read More
Dr Michael Portman Illuminates the Differences Between Pediatric, Adult Anticoagulation Studies
January 23rd 2023Pharmaceutical companies would have to spend a lot of money on pediatric anticoagulation studies for diseases that are rare among these patients, explained Michael A. Portman, MD, FAHA, of Seattle Children's Hospital.
Watch
Wildfire Air Pollution Linked With Increased Rates of Psoriasis Clinic Visits Among Adults
January 22nd 2023After a delayed lag period, air pollution from a wildfire was associated with modestly increased rates of clinic visits for psoriasis among adults starting 5 weeks after the fire and peaking at 8 to 9 weeks after the fire.
Read More
Dr Kirsten Johansen on Benefits of Oral Therapies for the Management of CKD
January 22nd 2023Kirsten Johansen, MD, director of nephrology, Hennepin Healthcare, speaks on the impact that an oral medication would have on the management of chronic kidney disease (CKD) for patients both on and not on dialysis.
Watch
Valproate Exhibits Both Hypnotic, Antiepileptic Properties During Sleep
January 21st 2023In an animal study, researchers found that valproate, a common epilepsy drug, possessed hypnotic and antiepileptic properties during sleep, suggesting that the drug could help improve sleep quality for patients with nocturnal epilepsy.
Read More
Motor Symptoms May Occur 3 Years Before Parkinson Disease Diagnosis, Study Says
January 20th 2023Trouble with balance and holding objects above one's head were just a few of the problems reported by patients 3 years before they received a formal Parkinson disease diagnosis, according to a recent study.
Read More
What We’re Reading: US Hits Debt Limit; More Oversight of Organics; Drug-Resistant Gonorrhea
January 20th 2023As the country hits the debt limit spending on Medicare and Medicaid may be at risk; the Agriculture Department targets fraudulent claims in products labeled as organic; first cases of drug-resistant gonorrhea strain found.
Read More
Examining the Links Between Asthma, Depression During the Pandemic in Canada
January 20th 2023The study sought to identify what factors were linked with developing depression in adults with asthma without a history of the disease, and to identify which factors were associated with recurrent depression during the pandemic in adults with both conditions.
Read More